Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Althobiani (London, United Kingdom), R. Evans (London, United Kingdom), J. Alqahtani (London, United Kingdom), A. Aldhahir (London, United Kingdom), J. Hurst (London, United Kingdom), J. Porter (London, United Kingdom). Domiciliary monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and/or progression: a systematic review. 2237

Member's Comments

No comment yet.

Related content which might interest you: Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review Source: ERJ Open Res, 7 (4) 00441-2021; 10.1183/23120541.00441-2021 Year: 2021 Optimizing chronic obstructive pulmonary disease (COPD) diagnosis and management to reduce healthcare costs: Systematic review and modeling Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 Acute exacerbations of chronic obstructive pulmonary disease: current recommendations review and quality of evidence analysis. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 The effect of methlyxanthines as adjunct to corticosteroids among chronic obstructuve pulmonary disease patients in acute exacerbation: a systematic review and meta-analysis Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Interstitial lung disease in childhood. A clinical review Source: Eur Respir J 2004; 24: Suppl. 48, 624s Year: 2004 Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care Source: Eur Respir J 2008; 32: 945-952 Year: 2008 Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review Source: ERJ Open Res, 7 (1) 00235-2020; 10.1183/23120541.00235-2020 Year: 2021 Recommendations for epidemiological studies on COPD Source: Eur Respir J 2011; 38: 1261-1277 Year: 2011 The future of disease monitoring and management: the homework for clinical researchers Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 The association between morning symptoms and physical activity in chronic obstructive pulmonary disease: A systematic review Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Early supported discharge/hospital at home for exacerbation of chronic obstructive pulmonary disease, A review and meta-analysis Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease: a Cochrane review update. Source: International Congress 2017 – Assessing and targeting functional outcomes in respiratory physiotherapy Year: 2017 A systematic review of the use of physiological tests assessing the acute response to treatment during exacerbations of COPD Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Can antibiotics prevent acute COPD exacerbation? A systematic review and meta-analysis Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases Source: International Congress 2014 – Markers Year: 2014 Prevalence of respiratory viral infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection Year: 2009 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Correlation of clinical, laboratory and functional parameters in stable chronic obstructive pulmonary disease Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014